CDH1 and CDH1-related diffuse gastric and lobular breast cancer syndrome: The growth-inhibition experiments described above focused on achieving chemoprevention in HDGC by inhibiting the survival of the CDH1-null multifocal stage T1a SRCCs that are present in CDH1 germline mutation carriers.